Cargando…

Antifungal Resistance Regarding Malassezia pachydermatis: Where Are We Now?

Malassezia pachydermatis is a yeast inhabiting the skin and ear canals in healthy dogs. In the presence of various predisposing conditions it can cause otitis and dermatitis, which are treated with multiple antifungal agents, mainly azole derivatives. This manuscript aims to review the available evi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peano, Andrea, Johnson, Elizabeth, Chiavassa, Elisa, Tizzani, Paolo, Guillot, Jacques, Pasquetti, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345795/ https://www.ncbi.nlm.nih.gov/pubmed/32630397 http://dx.doi.org/10.3390/jof6020093

Ejemplares similares

Methodological Issues in Antifungal Susceptibility Testing of Malassezia pachydermatis
por: Peano, Andrea, et al.
Publicado: (2017)

Azole resistance of Malassezia pachydermatis causing treatment failure in a dog
por: Angileri, Martina, et al.
Publicado: (2018)

A pilot study of the efficacy of wipes containing chlorhexidine 0.3%, climbazole 0.5% and Tris-EDTA to reduce Malassezia pachydermatis populations on canine skin
por: Cavana, Paola, et al.
Publicado: (2015)

Susceptibility variation of Malassezia pachydermatis to antifungal agents according to isolate source
por: Weiler, Caroline Borges, et al.
Publicado: (2013)

In vitro effects of omeprazole in combination with antifungal compounds against Malassezia pachydermatis
por: Shin, Juyoung, et al.
Publicado: (2023)

Malassezia pachydermatis Carriage in Dog Owners
por: Morris, Daniel O., et al.
Publicado: (2005)

Malassezia pachydermatis keratomycosis in a dog
por: Ledbetter, Eric C., et al.
Publicado: (2016)

In Vitro Biofilm Formation by Malassezia pachydermatis Isolates and Its Susceptibility to Azole Antifungals
por: Čonková, Eva, et al.
Publicado: (2022)

Malassezia pachydermatis fungemia in an adult with multibacillary leprosy
por: Roman, Jorge, et al.
Publicado: (2016)

Azole and terbinafine susceptibility testing of Malassezia pachydermatis in Japan
por: MURAYAMA, Nobuo, et al.
Publicado: (2023)

Susceptibility of Malassezia pachydermatis Clinical Isolates to Allopathic Antifungals and Brazilian Red, Green, and Brown Propolis Extracts
por: Deegan, Kathleen Ramos, et al.
Publicado: (2019)

Antifungal susceptibility of Malassezia pachydermatis isolated from the external auditive conduct from dogs, in central Chile
por: Núñez, Andrea H., et al.
Publicado: (2022)

First Case of Catheter-related Malassezia pachydermatis Fungemia in an Adult
por: Lee, Jaehyeon, et al.
Publicado: (2019)

New Therapeutic Candidates for the Treatment of Malassezia pachydermatis -Associated Infections
por: Sastoque, Angie, et al.
Publicado: (2020)

ERG11 Gene Variability and Azole Susceptibility in Malassezia pachydermatis
por: Díaz, Leyna, et al.
Publicado: (2022)

CLSI broth microdilution method for testing susceptibility of Malassezia pachydermatis to thiabendazole
por: Nascente, Patrícia da Silva, et al.
Publicado: (2009)

Malassezia pachydermatis fungemia in a preterm neonate resistant to fluconazole and flucytosine
por: Al-Sweih, Noura, et al.
Publicado: (2014)

Efficacy of Amitraz plus Metaflumizone for the treatment of canine demodicosis associated with Malassezia pachydermatis
por: Tarallo, Viviana D, et al.
Publicado: (2009)

In vitro antifungal activity of cold atmospheric microwave plasma and synergistic activity against Malassezia pachydermatis when combined with chlorhexidine gluconate
por: Lee, Tae‐Hyun, et al.
Publicado: (2022)

Genotyping and characterisation of the secretory lipolytic enzymes of Malassezia pachydermatis isolates collected from dogs
por: Teramoto, Hideshi, et al.
Publicado: (2015)

Draft Genome Sequence of the Animal and Human Pathogen Malassezia pachydermatis Strain CBS 1879
por: Triana, Sergio, et al.
Publicado: (2015)

A Ketoconazole Susceptibility Test for Malassezia pachydermatis Using Modified Leeming–Notman Agar
por: Hsieh, Bo-Young, et al.
Publicado: (2018)

Invasive Malassezia pachydermatis Infection in an 8-Year-Old Child on Lipid Parenteral Nutrition
por: Teoh, Zheyi, et al.
Publicado: (2022)

Galleria mellonella as a Novelty in vivo Model of Host-Pathogen Interaction for Malassezia furfur CBS 1878 and Malassezia pachydermatis CBS 1879
por: Torres, Maritza, et al.
Publicado: (2020)

Production of Antihypertensive Angiotensin I-Converting Enzyme Inhibitor from Malassezia pachydermatis G-14
por: Jeong, Seung Chan, et al.
Publicado: (2005)

In Vitro Activity of Farnesol against Malassezia pachydermatis Isolates from Otitis Externa Cases in Dogs
por: Olabode, Ifarajimi Rapheal, et al.
Publicado: (2023)

Novel Antimicrobial Peptide from Temporin L in The Treatment of Staphylococcus pseudintermedius and Malassezia pachydermatis in Polymicrobial Inter-Kingdom Infection
por: Bellavita, Rosa, et al.
Publicado: (2020)

In Vitro Susceptibility of Malassezia pachydermatis Isolates from Canine Skin with Atopic Dermatitis to Ketoconazole and Itraconazole in East Asia
por: WATANABE, Shion, et al.
Publicado: (2013)

A Cluster of Fluconazole-Resistant Malassezia pachydermatis in a Neonatal Intensive Care Unit — California, 2015–2016
por: Chinn, Raymond, et al.
Publicado: (2017)

Characterization of the species Malassezia pachydermatis and re-evaluation of its lipid dependence using a synthetic agar medium
por: Puig, Laura, et al.
Publicado: (2017)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Where are we now?
Publicado: (1977)

Whole-Genome Sequencing and De Novo Assembly of Malassezia pachydermatis Isolated from the Ear Canal of a Dog with Otitis
por: D’Andreano, S., et al.
Publicado: (2021)

The Current Evidence Regarding COVID-19 and Pregnancy: Where Are We Now and Where Should We Head to Next?
por: Kalampokas, Theodoros, et al.
Publicado: (2021)

Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

Yellow fever control in Cameroon: Where are we now and where are we going?
por: Wiysonge, Charles Shey, et al.
Publicado: (2008)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k0ai0gi98onbp0s8vrv4t5053s